return to news
  1. Stock Market Highlights: Markets trade lower; NIFTY50 down 1%; SENSEX sheds 740 points

Stock Market Highlights: Markets trade lower; NIFTY50 down 1%; SENSEX sheds 740 points

SUMMARY

Benchmark indices closed lower on Friday, with NIFTY50 declining 1% and SENSEX shedding 740 points. In the NIFTY50 space, 46 stocks were declining. Tata Steel, JSW Steel and BPCL were among the top losers.

card-img
  1. Markets trade lower; NIFTY50 down 1%; SENSEX sheds 740 points

    Benchmark indices closed lower on Friday, with NIFTY50 declining 1% and SENSEX shedding 740 points. In the NIFTY50 space, 46 stocks were declining. Tata Steel, JSW Steel and BPCL were among the top losers.

    July 19, 2024, 15:39 PM

  2. Markets trade lower; NIFTY50 down 1%; SENSEX sheds 600 points

    Benchmark indices were trading lower on Friday, with NIFTY50 declining 1% and SENSEX shedding 600 points. In the NIFTY50 space, 45 stocks were declining. Tata Steel, JSW Steel and Hindalco were among the top losers.

    July 19, 2024, 14:39 PM

  3. L&T Technology shares gains 1.3% as Q1 net profit grows marginally

    L&T Technology announced on Thursday a 0.8% year-on-year (YoY) rise in its Q1 net profit to ₹313 crore. The consolidated revenue for the quarter grew by 7% YoY to ₹2,461 crore. Following the announcement, shares of the company gained by 1.3% at ₹4,913.6 per share.

    July 19, 2024, 14:23 PM

  4. KPI Green Energy gets new 100 MW hybrid project

    KPI Green Energy on Friday said it has secured an order for 100 MW hybrid energy project from Aether Industries.

    The projects are scheduled to be completed in the financial year 2024-25, in various tranches as per the terms of the order, the company said in an exchange filing.

    July 19, 2024, 12:38 PM

  5. Zydus Lifesciences gets USFDA nod for diabetes drug

    Zydus Lifesciences on Friday said it has received approval from the US health regulator for its new drug application for a diabetes medication.

    The company has received final approval for its new drug application (NDA) from the US Food and Drug Administration (USFDA) to market Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release tablets, the drug firm said in a statement.

    July 19, 2024, 12:19 PM

  6. Paytm Q1 FY25 loss widens to ₹840 crore

    Fintech firm One97 Communications, which owns the Paytm brand, on Friday said its loss has widened to ₹840 crore in the quarter ended June 30, 2024.

    According to a regulatory filing, the company had posted a loss of ₹358.4 crore in the same period a year ago.

    July 19, 2024, 11:27 AM

  7. South Indian Bank gains over 4% post strong Q1 results

    South Indian Bank shares gained over 4% on Friday, July 19, after the private lender reported a 45.2% surge in its Q1 FY25 net profit to ₹294 crore, backed by lower provisions. The bank had reported a net profit of ₹202 crore in the year-ago period.

    July 19, 2024, 10:41 AM

  8. BSE SENSEX: Winners and losers at 9:47 am

    infowe.PNG

    July 19, 2024, 09:48 AM

  9. Markets open lower; NIFTY50 down 0.16%; SENSEX sheds 70 points

    Benchmark indices were trading lower on Friday, with NIFTY50 declining 0.16% and SENSEX shedding 70 points. In the NIFTY50 space, 40 stocks were declining. Powergrid, UltraTech Cement and BPCL were among the top gainers.

    July 19, 2024, 09:20 AM

  10. GIFT NIFTY trades flat, Asian markets down

    The GIFT NIFTY is trading flat, indicating a subdued-to-positive start for the Indian equities today. Meanwhile, other Asian markets are trading in the red, with Japan’s Nikkei 225 down 0.1% and Hong Kong’s Hang Seng index slipping nearly 2%.

    July 19, 2024, 08:30 AM